Literature DB >> 19811282

The translocation of HMGB1 during cell activation and cell death.

Julie Gauley1, David S Pisetsky.   

Abstract

High-mobility group box protein 1 (HMGB1) is a non-histone nuclear protein with alarmin activity. When present in an extracellular location, HMGB1 can activate the innate immune system and promote inflammation in conditions such as sepsis. To exert these activities, HMGB1 must transit from the nucleus, through the cytoplasm, to the outside of the cell. This process can occur during cell activation as well as cell death. In murine macrophages (MPhi), stimulation of TLR3 and TLR4, but not TLR9, can cause HMGB1 translocation. With cell death, necrosis can lead to extracellular HMGB1 by a passive mechanism. With apoptosis, HMGB1 is only released during secondary necrosis, when cell permeability barriers break down. Since agents that stimulate MPhi can also induce apoptosis, HMGB1 release following TLR stimulation may also reflect a contribution from dead cells, suggesting a common mechanism for protein release in activation and death.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19811282     DOI: 10.1080/08916930902831522

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  29 in total

Review 1.  Nucleic acid sensing receptors in systemic lupus erythematosus: development of novel DNA- and/or RNA-like analogues for treating lupus.

Authors:  P Lenert
Journal:  Clin Exp Immunol       Date:  2010-05-07       Impact factor: 4.330

Review 2.  Role of reactive oxygen and nitrogen species in the vascular responses to inflammation.

Authors:  Peter R Kvietys; D Neil Granger
Journal:  Free Radic Biol Med       Date:  2011-11-12       Impact factor: 7.376

3.  High-mobility group box-1 impairs memory in mice through both toll-like receptor 4 and Receptor for Advanced Glycation End Products.

Authors:  Andréy Mazarati; Mattia Maroso; Valentina Iori; Annamaria Vezzani; Mirjana Carli
Journal:  Exp Neurol       Date:  2011-08-22       Impact factor: 5.330

Review 4.  Contributions of nonhematopoietic cells and mediators to immune responses: implications for immunotoxicology.

Authors:  Barbara L F Kaplan; Jinze Li; John J LaPres; Stephen B Pruett; Peer W F Karmaus
Journal:  Toxicol Sci       Date:  2015-06       Impact factor: 4.849

5.  Macrophage-derived HMGB1 as a Pain Mediator in the Early Stage of Acute Pancreatitis in Mice: Targeting RAGE and CXCL12/CXCR4 Axis.

Authors:  Yuhei Irie; Maho Tsubota; Hiroyasu Ishikura; Fumiko Sekiguchi; Yuka Terada; Toshifumi Tsujiuchi; Keyue Liu; Masahiro Nishibori; Atsufumi Kawabata
Journal:  J Neuroimmune Pharmacol       Date:  2017-07-28       Impact factor: 4.147

6.  Hypoxia-induced HMGB1 in would tissues promotes the osteoblast cell proliferation via activating ERK/JNK signaling.

Authors:  Qiang Li; Bin Yu; Peng Yang
Journal:  Int J Clin Exp Med       Date:  2015-09-15

Review 7.  HMGB1 is a therapeutic target for sterile inflammation and infection.

Authors:  Ulf Andersson; Kevin J Tracey
Journal:  Annu Rev Immunol       Date:  2011       Impact factor: 28.527

8.  Temporal and spatial patterns of endogenous danger signal expression after wound healing and in response to lymphedema.

Authors:  Jamie C Zampell; Alan Yan; Tomer Avraham; Victor Andrade; Stephanie Malliaris; Seth Aschen; Stanley G Rockson; Babak J Mehrara
Journal:  Am J Physiol Cell Physiol       Date:  2011-01-19       Impact factor: 4.249

9.  Spontaneous Development of Hepatocellular Carcinoma and B-Cell Lymphoma in Mosaic and Heterozygous Brca2 and Cdkn1a Interacting Protein Knockout Mice.

Authors:  Huimei Lu; Caiyong Ye; Xing Feng; Jingmei Liu; Mantu Bhaumik; Bing Xia; Chen Liu; Zhiyuan Shen
Journal:  Am J Pathol       Date:  2020-03-20       Impact factor: 4.307

10.  Prevalence and clinical significance of sterile intra-amniotic inflammation in patients with preterm labor and intact membranes.

Authors:  Roberto Romero; Jezid Miranda; Tinnakorn Chaiworapongsa; Steven J Korzeniewski; Piya Chaemsaithong; Francesca Gotsch; Zhong Dong; Ahmed I Ahmed; Bo Hyun Yoon; Sonia S Hassan; Chong Jai Kim; Lami Yeo
Journal:  Am J Reprod Immunol       Date:  2014-07-31       Impact factor: 3.886

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.